Poliosis

Poliosis | Kardia Vision

Poliosis (Localized Loss of Pigment in Eyelashes & Eyebrows)

Poliosis is a condition characterized by localized loss of pigment in hair, resulting in white or depigmented eyelashes, eyebrows, or other hair. It occurs when melanocytes responsible for producing melanin are reduced, damaged, or dysfunctional.

Category Hair Pigmentation Disorder
Main Structures Melanocytes & Hair Follicles
Common Association Vitiligo & Autoimmune Disease
Main Finding White Eyelashes or Eyebrows

What Is Poliosis?

Poliosis is a localized absence or reduction of pigment in hair caused by decreased melanin production within affected hair follicles.


The condition most commonly affects eyelashes and eyebrows but may also involve the scalp, beard, or other body hair.


Unlike madarosis, which involves loss of hair, poliosis involves a change in hair color while the hair itself may remain present.


Poliosis may occur as an isolated finding or as part of a systemic, genetic, autoimmune, or inflammatory disorder.

Eyelash & Eyebrow Pigment Anatomy

Hair pigmentation depends on specialized cells within hair follicles that produce melanin.


Melanocytes

Specialized pigment-producing cells responsible for creating melanin.

Melanin Production

The process responsible for determining hair color.

Hair Follicles

Structures containing pigment-producing cells that generate eyelashes and eyebrows.

Hair Shaft

The visible portion of hair containing pigment.

Supporting Periocular Structures

Healthy eyelid and surrounding skin structures support normal eyelash growth and pigmentation.


Eyelashes

Protect the ocular surface and normally contain pigment from melanocytes.

Eyebrows

Help protect the eye from sweat and debris while contributing to facial expression.

Eyelid Margin

Contains eyelashes and important structures involved in eyelid function.

Skin Pigment Cells

Maintain normal pigmentation of surrounding periocular tissues.

Normal Hair Pigmentation vs Poliosis

Hair color depends on normal melanocyte activity within the follicle.


Normal Pigmented Hair

  • Healthy melanocyte function
  • Normal melanin production
  • Uniform hair color
  • Normal follicle activity

Poliosis

  • Reduced or absent pigment
  • White or gray hair appearance
  • May affect isolated areas
  • May indicate underlying disease

Types of Poliosis

Congenital Poliosis

Present from birth and may be associated with genetic disorders.

Acquired Poliosis

Develops later due to autoimmune disease, inflammation, or other causes.

Localized Poliosis

Pigment loss affecting a specific area of hair.

Segmental Poliosis

Affects a defined region or patch of hair.

Eyelash Poliosis

Loss of pigment specifically affecting eyelashes.

Eyebrow Poliosis

Depigmentation affecting eyebrow hairs.

Scalp-Associated Poliosis

Depigmentation involving scalp hair.

Isolated Poliosis

Occurs without an identifiable associated disorder.

Why Does Poliosis Occur?

Poliosis develops when melanocytes within hair follicles cannot produce normal amounts of pigment.


Melanocyte Dysfunction

Pigment-producing cells may become inactive or impaired.

Loss of Melanin Production

Reduced pigment production causes white or depigmented hair.

Autoimmune Destruction

The immune system may target melanocytes.

Genetic Disorders

Inherited conditions may affect pigment development.

Inflammatory Disease

Inflammation may interfere with melanocyte function.

Medication Effects

Certain treatments may alter pigmentation.

Common Causes & Risk Factors

Vitiligo

Autoimmune loss of pigment affecting skin and hair.

Waardenburg Syndrome

Genetic condition associated with pigment abnormalities.

Vogt-Koyanagi-Harada Disease

Inflammatory disorder affecting melanocyte-containing tissues.

Alopecia Areata

Autoimmune hair disorder that may involve pigment changes.

Ocular Inflammation

Inflammatory eye disease may be associated with pigment changes.

Uveitis

Inflammation involving pigmented ocular tissues.

Trauma

Injury may affect pigment-producing structures.

Medication Effects

Some medications may alter hair pigmentation.

Conditions Associated With Poliosis

Madarosis

Loss of hair may occur alongside pigment changes.

Vitiligo

Autoimmune depigmentation disorder commonly associated with poliosis.

Uveitis

Inflammatory eye disease involving pigmented structures.

Autoimmune Disease

Immune disorders may affect melanocyte function.

Alopecia Areata

May cause localized hair and pigment abnormalities.

Ocular Inflammation

Inflammation may affect periocular pigmentation.

Symptoms & Clinical Signs

Poliosis itself is usually painless and does not directly affect vision. However, the presence of white eyelashes or eyebrows may indicate an underlying ocular, dermatologic, autoimmune, or genetic condition.


Common Symptoms

  • White eyelashes
  • White eyebrows
  • Patchy hair depigmentation
  • Change in facial appearance
  • Cosmetic concerns
  • Associated skin color changes
  • Possible eye discomfort from underlying disease

Clinical Signs

  • Depigmented hair shafts
  • Normal hair density
  • Localized white hair patches
  • Skin depigmentation
  • Eyelid pigment changes
  • Associated ocular inflammation

Clinical Findings in Poliosis

The characteristic finding of poliosis is a localized area of white or gray hair caused by reduced melanin production.


Depigmented Hair Shafts

Affected eyelashes or eyebrows appear white due to reduced melanin content.

Normal Hair Density

Unlike madarosis, the number of hairs may remain normal.

Localized Pigment Loss

Only specific areas of hair may lose pigmentation.

Associated Skin Changes

Nearby skin may demonstrate depigmentation in disorders such as vitiligo.

Poliosis vs Madarosis

Although both conditions affect eyelashes and eyebrows, they represent different processes.


Poliosis

  • Hair is present
  • Pigment is reduced or absent
  • Hair appears white
  • Follicles may remain healthy

Madarosis

  • Hair is missing or reduced
  • May involve follicle damage
  • Can cause lash or brow thinning
  • May be scarring or non-scarring

Clinical Examination of Poliosis

Evaluation focuses on identifying pigment changes and determining whether an associated ocular or systemic disorder is present.


Eyelid Examination

Assesses eyelashes, eyelid margins, inflammation, and structural abnormalities.

Eyebrow Evaluation

Determines distribution and extent of pigment loss.

Slit Lamp Examination

Evaluates ocular structures for inflammatory disease.

Eyelid Examination

A detailed eyelid evaluation helps differentiate isolated poliosis from conditions affecting eyelid health.


Eyelash Color Assessment

Determines the extent and pattern of lash depigmentation.

Eyelid Margin Evaluation

Checks for inflammation, scarring, or associated blepharitis.

Hair Distribution

Determines whether pigment loss is localized or widespread.

Eyebrow Evaluation

The eyebrow examination provides clues about possible systemic or dermatologic conditions.


Pattern of Depigmentation

Determines whether pigment loss follows a specific pattern.

Associated Skin Changes

Looks for areas of vitiligo or other pigment disorders.

Symmetry

Helps distinguish isolated findings from systemic conditions.

Slit Lamp Examination

Slit lamp evaluation is important when poliosis is associated with ocular inflammation.


Anterior Segment Evaluation

Examines the eye for signs of inflammation.

Iris Evaluation

Assesses pigment changes associated with inflammatory disorders.

Anterior Chamber

Evaluates for cells and flare suggesting uveitis.

Ocular Surface

Assesses associated dryness or irritation.

Wood’s Lamp Examination

Wood’s lamp evaluation may help identify areas of skin depigmentation, particularly in suspected vitiligo.


Vitiligo Assessment

Depigmented areas may become more visible under ultraviolet light.

Skin Pigment Evaluation

Helps determine whether pigment loss extends beyond hair.

Evaluation for Ocular Inflammation

Poliosis associated with inflammation requires assessment for diseases involving pigment-containing ocular tissues.


Uveitis Evaluation

Checks for inflammatory cells within the eye.

VKH Disease Assessment

Evaluates for inflammatory findings associated with melanocyte disorders.

Retinal Evaluation

Assesses posterior segment involvement when indicated.

Assessing Severity of Poliosis

Severity is based on the amount of pigment loss, affected hair structures, and presence of associated disease.


Amount of Pigment Loss

Determines whether only a few hairs or a larger area is involved.

Number of Hair Involved

Assesses the extent of eyelash or eyebrow depigmentation.

Associated Skin Disease

Presence of vitiligo or other pigment disorders affects evaluation.

Ocular Involvement

Inflammatory eye disease may increase clinical significance.

Differential Diagnosis

Several conditions may resemble poliosis and should be distinguished during evaluation.


Madarosis

Loss of eyelashes or eyebrows rather than loss of pigment.

Premature Graying

Generalized age-related or early hair depigmentation.

Alopecia Areata

Autoimmune hair loss that may include pigment changes.

Vitiligo

Autoimmune depigmentation of skin and sometimes hair.

Chemical Bleaching

External products may alter hair color.

Associated Conditions

Vitiligo

Common autoimmune pigment disorder associated with poliosis.

Waardenburg Syndrome

Genetic disorder associated with pigment abnormalities.

Vogt-Koyanagi-Harada Disease

Inflammatory disorder affecting melanocyte-containing tissues.

Alopecia Areata

Autoimmune disorder affecting hair follicles.

Autoimmune Disorders

Immune-mediated conditions may affect melanocyte function.

Key Clinical Questions

When Did Pigment Loss Begin?

Helps differentiate congenital from acquired causes.

Is Skin Depigmentation Present?

May suggest vitiligo or pigment disorders.

Are There Eye Symptoms?

May indicate associated ocular inflammation.

Treatment Options for Poliosis

Treatment of poliosis depends on the underlying cause, presence of associated disease, and whether pigment-producing melanocytes can recover.


Observation

Isolated and stable poliosis without associated disease may only require monitoring.

Treat Underlying Cause

Management focuses on controlling autoimmune, inflammatory, or genetic conditions.

Cosmetic Management

Used when pigment changes affect appearance or quality of life.

Observation and Monitoring

Some cases of poliosis remain stable and do not require active treatment.


Isolated Poliosis

Patients without symptoms or associated disease may be monitored periodically.

Monitor Progression

Follow-up helps identify new pigment loss or development of systemic disease.

Ocular Screening

Patients with ocular symptoms may require evaluation for inflammation.

Treating the Underlying Cause

Because poliosis is often a sign of another condition, identifying and treating the cause is the primary goal.


Autoimmune Disease Management

Treatment focuses on reducing immune activity affecting melanocytes.

Inflammatory Disease Treatment

Controlling inflammation may prevent further pigment changes.

Vitiligo Management

Treatment may include therapies aimed at restoring or stabilizing pigment.

Uveitis Treatment

Inflammatory eye disease requires appropriate ocular therapy.

Autoimmune-Related Poliosis Treatment

Autoimmune disorders may cause melanocyte dysfunction or destruction.


Corticosteroids

May reduce autoimmune inflammation in selected conditions.

Immunomodulatory Therapy

Used when immune activity contributes to pigment loss.

Systemic Evaluation

Assessment may be needed to identify associated autoimmune disorders.

Vitiligo-Associated Poliosis Management

When poliosis occurs with vitiligo, treatment focuses on controlling pigment loss and improving appearance.


Topical Corticosteroids

May help stimulate repigmentation in selected areas.

Topical Immunomodulators

May regulate immune activity affecting melanocytes.

Phototherapy

Ultraviolet-based treatments may promote repigmentation in some patients.

Uveitis-Associated Poliosis Treatment

Poliosis associated with ocular inflammation requires evaluation and treatment of the inflammatory disease.


Anti-Inflammatory Therapy

Controls inflammation affecting ocular tissues.

Ocular Monitoring

Regular examinations monitor disease activity.

Vision Protection

Early management reduces risk of inflammatory complications.

Medical Treatment Options

Specific therapy depends on the cause and extent of pigment loss.


Corticosteroids

Used for inflammatory and autoimmune conditions when appropriate.

Immunomodulators

Help regulate abnormal immune responses.

Phototherapy

May assist repigmentation in certain pigment disorders.

Supportive Care

Protects skin and ocular health while monitoring progression.

Cosmetic Management of Poliosis

When pigment loss is permanent or primarily cosmetic, several options may improve appearance.


Eyebrow Makeup

Cosmetic products can restore the appearance of eyebrow color.

Eyelash Tinting

May temporarily improve eyelash appearance.

Cosmetic Camouflage

Specialized cosmetic techniques may reduce visible pigment differences.

Microblading

Creates the appearance of eyebrow pigmentation.

Eyelash Restoration Considerations

Patients with permanent cosmetic concerns may consider restorative options after the underlying condition is controlled.


Potential Options

  • Eyelash tinting
  • Cosmetic enhancement
  • Eyelash transplantation

Important Considerations

  • Active inflammation should be controlled
  • Underlying disease should be evaluated
  • Results vary between patients

Eyebrow Restoration

Eyebrow restoration may be considered when poliosis causes persistent cosmetic concerns.


Microblading

Creates the appearance of natural eyebrow hairs.

Eyebrow Transplantation

Uses transplanted follicles to restore eyebrow density.

Cosmetic Products

Temporary solutions for color enhancement.

Hair Transplantation Considerations

Hair transplantation may be considered in selected patients with stable, permanent pigment or hair changes.


Candidate Selection

Patients should have stable disease and healthy donor follicles.

Benefits

May improve cosmetic appearance.

Limitations

Does not treat the underlying cause of pigment loss.

Post-Treatment Care

Follow-up is important to monitor pigment changes and associated conditions.


Follow-Up Visits

Monitor progression and treatment response.

Monitor Ocular Disease

Patients with inflammatory conditions require ongoing eye evaluations.

Skin Protection

Sun protection is important in areas with pigment loss.

Complications of Poliosis Treatment

Recurrence

Pigment loss may return if the underlying disease remains active.

Skin Irritation

Topical treatments may cause redness or irritation.

Incomplete Pigment Recovery

Damaged melanocytes may not fully recover.

Preventing Progression of Poliosis

Early Evaluation

Identifying associated disease early improves management.

Control Inflammation

Managing inflammatory disorders helps prevent progression.

Routine Eye Care

Regular examinations monitor ocular involvement.

Complications of Poliosis

Poliosis itself is usually a cosmetic finding; however, complications may arise from associated autoimmune, inflammatory, or genetic disorders.


Ocular Complications

  • Associated uveitis
  • Chronic ocular inflammation
  • Ocular surface irritation
  • Vision-threatening inflammatory disease
  • Need for long-term eye monitoring

Systemic & Cosmetic Effects

  • Progressive pigment loss
  • Association with autoimmune disease
  • Changes in facial appearance
  • Psychological impact
  • Reduced self-confidence

Associated Autoimmune Disease

Poliosis may be a visible sign of autoimmune activity affecting melanocytes, which are pigment-producing cells.


Vitiligo

Autoimmune destruction of melanocytes causing loss of pigment in skin and hair.

Alopecia Areata

Immune-mediated hair follicle disorder that may cause pigment changes.

Vogt-Koyanagi-Harada Disease

Inflammatory disorder targeting melanocyte-containing tissues.

Autoimmune Screening

Patients may require evaluation for additional autoimmune findings.

Ocular Inflammation Associated With Poliosis

When poliosis occurs with eye inflammation, evaluation is necessary because some inflammatory diseases can affect vision.


Uveitis

Inflammation inside the eye that may be associated with pigment disorders.

Anterior Segment Inflammation

May cause redness, pain, and light sensitivity.

Posterior Segment Disease

Inflammation affecting the retina or choroid requires monitoring.

Cosmetic Impact of Poliosis

White eyelashes or eyebrows may be noticeable and may affect appearance, especially when involving the facial region.


Common Concerns

  • Visible white lashes or brows
  • Changes in facial appearance
  • Difficulty matching cosmetic appearance
  • Concern about underlying disease

Management Options

  • Cosmetic camouflage
  • Eyebrow enhancement
  • Eyelash tinting
  • Restorative procedures

Psychological Effects

Visible pigment changes may affect emotional well-being, especially when the condition develops suddenly.


Self-Image Concerns

Patients may feel concerned about changes in appearance.

Social Impact

Cosmetic differences may affect confidence in social situations.

Patient Support

Education and reassurance help patients understand the condition.

Progressive Pigment Loss

Some patients may experience progression if the underlying inflammatory or autoimmune process remains active.


Localized Progression

Pigment loss may expand to nearby hairs.

Generalized Pigment Changes

Some systemic disorders may cause widespread depigmentation.

Monitoring

Follow-up helps detect changes early.

Prognosis

The prognosis of poliosis depends on the underlying cause and whether melanocytes remain functional.


Isolated Poliosis

Often remains stable and does not affect vision.

Autoimmune-Related Poliosis

Course depends on control of the underlying immune condition.

Genetic Poliosis

Usually remains stable but may be associated with other findings.

Clinical Pearls

  • Poliosis is loss of pigment, not loss of hair.
  • White eyelashes with normal lash density suggest poliosis rather than madarosis.
  • Vitiligo is one of the most common acquired associations.
  • Sudden-onset poliosis may require evaluation for autoimmune or inflammatory disease.
  • Always evaluate for ocular inflammation when poliosis is associated with eye symptoms.
  • Poliosis may occur with Vogt-Koyanagi-Harada disease and other melanocyte disorders.
  • Treatment focuses on the underlying condition rather than the pigment change alone.
  • Cosmetic treatments may improve appearance when pigment recovery is limited.

Common ICD-10 Codes

Code Description
L81.9 Disorder of pigmentation, unspecified
L80 Vitiligo
H20.9 Unspecified iridocyclitis (uveitis)
H44.89 Other disorders of eye
L63.9 Alopecia areata, unspecified

Patient Education: Living With Poliosis

Monitor Changes

Report new pigment loss or changes in other body areas.

Protect Skin

Use sun protection in areas with reduced pigment.

Maintain Eye Exams

Regular eye evaluations are important when associated with inflammation.

Address Cosmetic Concerns

Safe cosmetic options can improve appearance.

Frequently Asked Questions

What is poliosis?

Poliosis is localized loss of pigment causing white or depigmented hair, commonly affecting eyelashes or eyebrows.

Is poliosis the same as madarosis?

No. Poliosis affects hair color, while madarosis involves loss of eyelashes or eyebrows.

Can poliosis go away?

Some cases may remain stable, while others may improve if the underlying cause is treated.

Does poliosis affect vision?

Poliosis itself does not usually affect vision, but associated inflammatory conditions may.

Should patients with poliosis see an eye doctor?

Evaluation is recommended if poliosis is new, progressive, or associated with eye symptoms.

Related Eye Conditions

Madarosis

Loss of eyelashes or eyebrows rather than pigment change.

Vitiligo

Autoimmune depigmentation disorder associated with poliosis.

Alopecia Areata

Autoimmune hair disorder that may involve eyelashes.

Uveitis

Inflammatory eye disease associated with pigment disorders.

Vogt-Koyanagi-Harada Disease

Inflammatory disorder affecting melanocyte-containing tissues.

Blepharitis

Chronic eyelid inflammation affecting periocular structures.

Ocular Melanoma

Tumor involving pigment-producing cells of the eye.

Medical Disclaimer

The information provided by Kardia Vision is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.


New pigment changes, eye pain, redness, light sensitivity, or vision changes should be evaluated by a qualified eye care professional.


Kardia Vision is dedicated to providing accurate, evidence-based eye health education for patients, students, and healthcare professionals.

Kardia Vision
Educational Eye Care Resource Center